Titanium dioxide nanoparticles have been synthesised using bulb extract of Ledebouria revoluta. The prepared TiO2 nanoparticles were characterised by structural (XRD, FTIR), morphological (HRTEM) and optical (UV-Vis) analysis. XRD shows the bioengineered TiO2 nanoparticles exhibit an average crystalline size of 47 nm with tetragonal structure. In FTIR spectra, the peak 482 cm−1 is indicating the presence of Ti-O stretching vibration. The morphology of bioengineered TiO2 nanoparticles shows a spherical shape. Antibacterial activity of L. revoluta bulb aqueous extract and TiO2 nanoparticles were evaluated against human pathogens. The larvicidal activity of TiO2 nanoparticles showed LC50 (18.960 mg/mL) and LC90 (77.097 mg/mL) against Aedes aegypti. Anti-lung cancer activity of TiO2 nanoparticles was examined using MTT assay and it results in IC50 value of 53.65 µg/mL. Furthermore, bioengineered TiO2 nanoparticles will be applicable to pharmaceutical applications.
No takes yet. Share an insight, caveat, or question.
Aswini et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: